VIVUS Inc. is a biopharmaceutical company that is currently focused on developing therapies that tackle diseases such as obesity, sleep apnea, diabetes, and male sexual health. One of its key products, Qnexa, has successfully completed Phase 3 clinical trials for obesity treatment and is also in Phase 2 clinical development for sleep apnea and diabetes. The company continues to move forward with its research and development efforts to tackle some of the most pressing health issues affecting populations today.
VIVUS, Inc's ticker is VVUS
The company's shares trade on the NASDAQ stock exchange
They are based in Mountain View, California
There are 51-200 employees working at VIVUS, Inc
It is http://www.vivus.com/
VIVUS, Inc is in the Healthcare sector
VIVUS, Inc is in the Biotechnology industry
The following five companies are VIVUS, Inc's industry peers: